These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 16258815)

  • 41. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria.
    Kilcher S; Studer P; Muessner C; Klumpp J; Loessner MJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):567-572. PubMed ID: 29298913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Reed E; Ding L; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):309-17. PubMed ID: 16391831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance in antimicrobial photodynamic inactivation of bacteria.
    Maisch T
    Photochem Photobiol Sci; 2015 Aug; 14(8):1518-26. PubMed ID: 26098395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Phage Therapy in the Context of
    Bolocan AS; Upadrasta A; Bettio PHA; Clooney AG; Draper LA; Ross RP; Hill C
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31010053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.
    Fischetti VA
    Int J Med Microbiol; 2010 Aug; 300(6):357-62. PubMed ID: 20452280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review: phage therapy: a modern tool to control bacterial infections.
    Qadir MI
    Pak J Pharm Sci; 2015 Jan; 28(1):265-70. PubMed ID: 25553704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacteriophages as an alternative strategy for fighting biofilm development.
    Parasion S; Kwiatek M; Gryko R; Mizak L; Malm A
    Pol J Microbiol; 2014; 63(2):137-45. PubMed ID: 25115107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Walkty A; Adam HJ; Laverdière M; Karlowsky JA; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):348-55. PubMed ID: 21353964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria.
    Wang F; Xiong Y; Xiao Y; Han J; Deng X; Lin L
    Virol J; 2020 Aug; 17(1):130. PubMed ID: 32843096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phage infection and sub-lethal antibiotic exposure mediate Enterococcus faecalis type VII secretion system dependent inhibition of bystander bacteria.
    Chatterjee A; Willett JLE; Dunny GM; Duerkop BA
    PLoS Genet; 2021 Jan; 17(1):e1009204. PubMed ID: 33411815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
    Garrison MW; Mutters R; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriophage-derived endolysins to target gram-negative bacteria.
    Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
    Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
    Cherif H; Kronvall G; Björkholm M; Kalin M
    Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.